Homepage
IMI impact event series – registration open!
Registration is now open for a series of online events in June that will showcase IMI’s impact in three areas: diabetes, dementia, and data management. During the events, experts including patients will explore the challenges and demonstrate how IMI has contributed to moving these fields forward.
New institute to act as catalyst for wider use of real-world evidence in healthcare decision-making in Europe
New institute to act as catalyst for wider use of real-world evidence in healthcare decision-making in Europe moreBig data study leads to identification of blood biomarkers for Alzheimer’s
Big data study leads to identification of blood biomarkers for Alzheimer’s moreUS regulator to expedite review of gut microbiome protector product from COMBACTE partner
US regulator to expedite review of gut microbiome protector product from COMBACTE partner more
IMI – radical collaboration in action
A new brochure, 'IMI - radical collaboration in action', showcases some recent IMI project successes, which include an approved vaccine for Ebola, insights into the genetics of Alzheimer’s disease, a new classification of diabetes, and advances on using liquid biopsies for cancer, as well as contributions to the fight against COVID-19.
IMI covid-19 response
Within weeks of the first reports of coronavirus in Europe, IMI launched a fast-track Call for proposals to develop therapeutics and diagnostics for current and future coronavirus outbreaks